Clover’s way better story
Directorate and management
The Board is ultimately responsible for the management of Clover’s business and determining its strategy and policies.
In addition, the Board is responsible for approving Clover’s financial objectives and targets. Clover’s Executive Directors, who are members of the Executive Committee, are involved in the day-to-day business activities and are responsible for ensuring that Board decisions are implemented in accordance with Board approved mandates.

Executive Committee
![]() |
![]() |
DR JAMES HENRY FERREIRA BOTES (54) Executive Appointed Qualification |
HENDRIKUS LUBBE (47) Executive Appointed Qualification |
![]() |
![]() |
MARCELO MARQUES PALMEIRO (51) Executive Appointed Qualification |
JACQUES VAN HEERDEN (32) Executive Legal, Secretarial and Human Resources Appointed 2014 Qualification LLB (Cum Laude), ACIS |
BOARD OF DIRECTORS |
|
Executive directors |
|
![]() |
![]() |
ELTON RONALD BOSCH (40)* Chief Financial Officer and Executive Appointed Qualification Role at Clover |
JOHANN VORSTER (53) Chief Executive Appointed Qualification Role at Clover |
Non-executive directors |
|
![]() |
![]() |
WERNER IGNATIUS BÜCHNER (51) Chairman Appointed Qualification Role at Clover |
THOMAS ALEXANDER WIXLEY (77)** Lead Independent Director Appointed Qualification Role at Clover |
![]() |
![]() |
BABALWA NGONYAMA (43) Independent Non- Executive Appointed Qualification Role at Clover |
NIGEL ATHOL SMITH (61) Non-Executive Appointed Qualification Role at Clover |
![]() |
![]() |
NEO VIOLET MOKHESI (56) Independent Non- Executive Appointed Qualification Role at Clover |
JOHANNES NICOLAAS STEPHANUS DU PLESSIS (67)*** Independent Non- Executive Appointed Qualification Role at Clover |
![]() |
![]() |
PETER RONALD GRIFFIN (58)** Non-Executive Appointed Qualification |
DR STEFANES FRANCOIS BOOYSEN (54) Lead Independent Director**** Appointed Qualification Role at Clover |
* To resign as from 31 December 2017
** Retired as from 28 November 2016
*** Resigned as from 11 January 2017
**** Effective 28 November 2016
Board Committees
| AUDIT AND RISK COMMITTEE | REMUNERATION COMMITTEE | SOCIAL AND ETHICS COMMITTEE | INVESTMENT COMMITTEE | NOMINATION COMMITTEE | |||||
| TA Wixley (retired 28 November 2016) | 2/2 | TA Wixley (retired 28 November 2016) | 1/1 | TA Wixley (retired 28 November 2016) | 2/2 | TA Wixley (retired 28 November 2016) | 1/1 | TA Wixley (retired 28 November 2016) | 1/1 |
| Dr SF Booysen | 4/4 | Dr SF Booysen | 3/3 | Dr SF Booysen | 4/4 | Dr SF Booysen | 3/3 | Dr SF Booysen | 2/2 |
| JNS du Plessis (retired 11 January 2017) | 2/2 | JNS du Plessis (retired 11 January 2017) | 1/1 | NV Mokhesi | 4/4 | WI Buchner | 3/3 | WI Buchner | 2/2 |
| B Ngonyama | 4/4 | WI Buchner | 3/3 | ER Bosch (to resign as from 31 December 2017) | 4/4 | NA Smith | 3/3 | NV Mokhesi (joined 28 November 2016) | 1/1 |
| NV Mokhesi (joined 1 January 2017) | 2/2 | NV Mokhesi | 1/1 | N Smith | 2/2 | B Ngonyama (joined 1 January 2017) | 0/1 |
Board Meetings
| TA Wixley (retired 28 November 2016) | 1/1 |
| Dr SF Booysen | 5/5 |
| JNS du Plessis (resigned 11 January 2017) | 3/3 |
| B Ngonyama | 5/5 |
| NV Mokhesi | 5/5 |
| WI Büchner | 5/5 |
| NA Smith | 5/5 |
| PR Griffin (retired 28 November 2016) | 1/1 |
| JH Vorster | 5/5 |
| ER Bosch (resigned effective 31 December 2017) | 5/5 |




















